ACC.21 Congress (American College of Cardiology 2021 Congress) (Videos)

Regular price
$75.00
Sale price
$75.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

ACC.21 Congress (American College of Cardiology 2021 Congress) (Videos)

*American College of Cardiology 2021 Congress*

ACC.21, the All Virtual Experience, will feature late-breaking clinical research and education across 11 learning pathways in an engaging and interactive forum providing the latest practice-changing updates in care.

From May 15 – 17, ACC.21 streamed to thousands of members of the cardiovascular team from around the world! Take time to explore ALL the education from ACC.21 with On Demand access. Watch 300+ sessions featuring practice-changing research and cutting-edge education. Plus, don’t miss the more than 3,3000 eAbstracts, 100+ exhibitors, and the opportunity to celebrate the achievements of our colleagues with Convocation. Sample from an unparalleled array of education when it’s convenient for you — from your home, office, or on-the-go — across 11 learning pathways. ACC.21 will leave you up to date on the newest clinical research and you’ll find out how it all impacts the care of your patients.


*Contents: (297 videos)

| 406 Joint American College of CardiologyJournal of the American Medical Association Late-Breaking Clinical Trials.ts

| 407 Joint American College of CardiologyNew England Journal of Medicine Late-Breaking Clinical Trials.ts

| 411 Late-Breaking Clinical Trials V.ts

| 908 Highlighted Original Research Multimodality Imaging and the Year in Review.ts

| 910 Highlighted Original Research Ischemic Heart Disease and the Year in Review.ts

| A Contemporary Understanding of the Diagnosis and Management of Low Flow Low Gradient Severe Aortic Stenosis.ts

| A Melting Pot of Clinical Valvular Heart Disease Cases No Cookbook, but a Practical Applications from the Valve Guidelines.ts

| A Practical Approach to Shared Decision Making when Treating Heart Valve Disease.ts

| A Review of the RADIANCE-HTN Global Clinical Trial Program A Focus on the TRIO cohort.ts

| ACC Cardiology Hour.ts

| ACC.21 Highlights in Hypertension.ts

| ACC21-Frequently-Asked-Questions-UPLOADED-May-11-2021.pdf

| Acing the Transition What FITs Need to Know to Launch a Healthy, Successful Career.ts

| Adult Congenital Heart Disease Cases That Stumped Me.ts

| Advanced Nuclear Cardiology Applications in 2021.ts

| Advances and new studies for the treatment of MR with Abbott’s TMV repair and replacement therapies.ts

| Advancing Patient Care Across the Heart Failure Continuum.ts

| Advancing Systems of Care in STEMI, Stroke, Cardiac Arrest, Shock.ts

| Anticoagulation Trivia from A to V Management Strategies Across the Board Meeting on Demand.mp4

| Antithrombotic Controversies in the Cath Lab.ts

| Antithrombotic Management in Patients with Atrial Fibrillation Undergoing PCI.ts

| Aortic Valve Interventions Clinical Dilemmas.ts

| Aortic Valve Interventions Expanding Indications.ts

| Application of Dual Source CT in cardiac imaging – a focus on Structural Heart Disease.ts

| Applying the Guidelines For Lipid Management in Special Populations.ts

| Arrhythmogenic Cardiomyopathies Tell Me What I Need to Know.ts

| ASCVD Risk Factors and Beyond.ts

| Atrial Fibrillation Management in Athletes.ts

| Best of JACC Journals & Eugene Braunwald Keynote.ts

| Best Practices of Multimodality Imaging in Percutaneous Mitral Interventions.ts

| Beyond a Broken Heart Multisystem Disease Burden in hATTR Amyloidosis.ts

| Beyond Atrial Fibrillation – Atrial Cardiopathy as a Cause of Cryptogenic Stroke.ts

| Bleeding Reduction Strategies Following PCI.ts

| Breakthrough Transcatheter Pulmonary Valve Treatment Option for Adult and Pediatric CHD Patients.ts

| Cardiac CT in Clinical Practice.ts

| Cardiac Culture Medium Current Concepts in Infective Endocarditis.ts

| Cardiac Imaging in Older Adults Overused or Underutilized Practical Points for Clinicians.ts

| Cardiac Point of Care Ultrasound Around the World.ts

| Cardiac Rehab Move to Improve.ts

| Cardio-Oncology Today’s Standard of Practice.ts

| Cardiogenic Shock Progress, Paradigms and Unresolved Problems.ts

| Cardiogenic Shock Teams and Devices for Cardiogenic Shock.ts

| Cardiologist Versus Calcium Unstoppable Force Meets Immovable Object.ts

| Cardiovascular Considerations in Amateur and Professional Athletes.ts

| Cardiovascular Imaging For Diagnosis And Management of Coronary Microvascular Disease.ts

| Cardiovascular Imaging to Enhance Prevention.ts

| Caring for the Patient with STEMI in 2021.ts

| Case Based Learning for the Cardiovascular Team.ts

| Cases from the Guidelines for Clinicians.ts

| CCM® Therapy – A Device Based Approach for the Treatment of Heart Failure.ts

| Challenges of Transplantation in Congenital Heart Disease Patients Ethics, Listing Strategy & MCS.ts

| Challenging Cases in Cardio-Oncology.ts

| Chest Pain Evaluation in 2021 Same Problem, New Tools, New Questions.ts

| Clarity From Confusion in Heart Failure With Preserved Ejection Fraction (HFpEF).ts

| Clinical Trials Research Upping Your Game.ts

| Clinical Trials ThunderDome Who Will Be Crowned Most Impactful.ts

| Complex and High-Risk PCI Case Based Joint Symposium.ts

| Complex Case-Based Decision-Making – The Heart Team in Action A Joint Symposium by TCT.ts

| Complex Dilemmas in Valvular Heart Disease.ts

| Contemporary Aortic Valve Disease Management.ts

| Contemporary Challenges in Cardiac Critical Care Structure, Staffing, Training and Beyond.ts

| Controversial Topics in Cardiac Transplantation and Ventricular Assist Devices.ts

| Controversies in Arrhythmia Therapy.ts

| Controversies in Interventional and Surgical Management of Congenital Heart Disease.ts

| Controversies in the ICU Management of Congenital Heart Disease.ts

| Core Knowledge in Action Essentials of Stable Ischemic Heart Disease.ts

| Core Knowledge in Action Return to the Basics of Aortic Stenosis.ts

| Core Knowledge in Action The Ultimate Guide to Lipids.ts

| Core Knowledge in Action What Everyone Ought To Know About HFpEF.ts

| Coronary Artery Disease – Atherogenesis, Acute Coronary Syndromes and Stroke.ts

| Coronary IVL’s Who, What, Where, When & Why An Introductory Guide for Clinical Practice.ts

| COVID 19 and Heart Failure Lessons Learned and Future Directions.ts

| COVID-19 and Echocardiography – Impact, Imaging, and Innovation.ts

| Critical Clinical Conundrums in Acute Coronary Syndromes.ts

| Current Approaches to Antiplatelet Therapy for PCI in Acute Coronary Syndrome.ts

| Current Controversies And Debates in CAD Imaging.ts

| CVD Prevention in the Post-COVID19 Era2.ts

| Debates in Arrhythmia Management in Congenital Heart Disease.ts

| Debates Should We Tailor Antiplatelet Therapy for PCI.ts

| Debating Controversies in STEMI Care.ts

| Deep Dive I.ts

| Deep Dive II.ts

| Destined to Fail How to Prevent Heart Failure.ts

| Diabesity A Tale of Obesity, Inflammation and Cardiometabolic Risk.ts

| Diabetes and Heart Failure.ts

| Diagnostic Testing in Stable Ischemic Heart Disease Choosing Wisely.ts

| Disparities and the Role of Social Determinants of Health in Acute and Stable Ischemic Heart Disease.ts

| Dissecting the Data Discussions on the Management of SCAD.ts

| Doorways To The Heart Valves In Systemic Disease.ts

| Drug Jeopardy Pharmacological Conundrums in Arrhythmia Management.ts

| ECGs With the Experts Practical Considerations For the Cardiovascular Clinician.ts

| Electrical Disorders – Rhythm and Conduction Disorders.ts

| Emerging Technologies in Vascular Disease.ts

| Endovascular Skills Basics to Bailout Techniques.ts

| EP Issues in Cancer Patients – Beyond Heart Failure.ts

| Essential Vascular Pearls for the Cardiovascular Clinician.ts

| Essentials of Atrial Fibrillation Management – Learn From the Experts.ts

| Evolution of Aortic Valve Replacement in Low-Risk Patients.ts

| Expanding Frontiers in Vascular Intervention.ts

| Expanding the Toolkit Tackling Residual Atherogenic Lipid Risk.ts

| Exploring New Synergies Integrating a Cardiac CT Scanner and Interventional C-arm in our Cath Lab.ts

| Featured Clinical Research I.ts

| Featured Clinical Research II.ts

| Featured Clinical Research III.ts

| Fellows Bootcamp Coronary and Peripheral Disease Management – The Best Cases You Have Seen Yet.ts

| Fellows Bootcamp Structural.ts

| FIT Forum Stump the Professor.ts

| FIT Jeopardy Battle of the State Chapters Finals.ts

| Focus on Interventional Complications.ts

| Four Models of Myocardial Disease & Heart Failure – Myocarditis, HFrEF, HFpEF, HCM.ts

| From Controversy to Clarity in Weight Loss Therapies.ts

| Fusion imaging for transcatheter edge-to-edge mitral valve repair.ts

| Gender-Specific Care of Patients with Acute Coronary Syndrome.ts

| Genetics through Geriatrics – CV Prevention Through the Lifespan.ts

| Getting to the Root of Dietary Effects.ts

| Getting Your Life-and-Style Back in CVD.ts

| Global Burden of Cardiovascular Disease in Women.ts

| Global Leadership and Professional Education in the COVID-19 Era.ts

| Great Debates in Vascular Medicine.ts

| Harnessing the Power of Technology Remote Monitoring and Management in HF.ts

| Help LDL.ts

| Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI (2).ts

| Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI.ts

| Hemodynamics of Heart Failure You Thought You Knew Them.ts

| Heterotaxy Syndrome or Somerism Whose Side Are You On.ts

| Highlighted Original Research Electrophysiology and the Year in Review.ts

| Highlighted Original Research Heart Failure and Cardiomyopathies and the Year in Review.ts

| Highlighted Original Research Interventional and Structural and the Year in Review.ts

| Highlighted Original Research Pediatric and Congenital Heart Disease and the Year in Review.ts

| Highlighted Original Research Prevention and Health Promotion and the Year in Review.ts

| Highlighted Original Research Pulmonary Vascular Disease and the Year in Review.ts

| Highlighted Original Research Valvular Heart Disease and the Year in Review.ts

| Highlighted Original Research Vascular Medicine and the Year in Review.ts

| Holy Estrogen! Sex Disparities in Heart Failure Therapies Biology, Bias or Both.ts

| How Can I Tell If This Aortic Valve Replacement Is Functioning Normally.ts

| How does Paradise Renal Denervation Fit Into Hypertension Treatment Management.ts

| How Much is Too Much Navigating Medication Overload by Medication Deprescribing.ts

| How to be an Effective Mentor & Mentee.ts

| How to Become a Successful Researcher at Every Stage of Your Career.ts

| How to Choose and Optimize Pacing in Patients with Heart Failure Conduction System Pacing and CRT.ts

| How to Deal With Cases That Go From No Problem to Nightmare.ts

| How to Stent a LM Like a Boss Left Main PCI Workshop.ts

| Hypertension Guidelines Do They Vary Across the World as Much as My Blood Pressure Has Today .ts

| Hypertension Management A Future Full of Promises.ts

| I Know the Evidence So How Do I Incorporate Nutrition and Lifestyle in My Clinic.ts

| Imagination is Everything Innovations in the Cath Lab.ts

| Imaging Cardiomyopathies Challenging Cases.ts

| Imaging Decision Making in Everyday Clinical Practice for Coronary Artery Disease.ts

| Imaging of Congenital Heart Disease Seeing Things We Never Saw Before.ts

| Implementing Rhythm Control Guidelines in Atrial Fibrillation The Good, The Bad, and The Ugly.ts

| Indirect Valvular Heart Disease Problems and Perspectives.ts

| Innovative Nutritional and Dietary Approaches for Cardiometabolic Disease.ts

| Insight of BAV Disease from Asia and Western Perspectives.ts

| International Centers of Excellence Todays Solutions for an Improved Tomorrow.ts

| Interventional Challenging Cases II An Interventional & SHD Potpourri Not to Miss.ts

| Interventional Challenging Cases Will Make You Think.ts

| Invasive Imaging and Physiology Diagnosis and Management of ACS Patients and Plaques.ts

| Is the Quality of Cardiovascular Research Declining What Research Should Continue to be Pursued.ts

| Jardiance® (empagliflozin) tablets The Impact of EMPA-REG OUTCOME.ts

| Jeopardy.ts

| Journey of the Right Ventricle in Pulmonary Hypertension.ts

| Kick Starting Your Research Career.ts

| Late-Breaking Clinical Trials IV.ts

| Late-Breaking Clinical Trials.ts

| Launching a Successful Career in Academic Cardiology Key Points to Success.ts

| Left Atrial Appendage Occlusion Clinical Challenges.ts

| Left Ventricular Ejection Fraction Past, Present, and Future Role in Heart Failure Care.ts

| Let’s Get Physical! Exercise and Cardiovascular Health.ts

| Lifelong Impact of Cardiovascular Risk Factors in Patients with Congenital Heart Disease.ts

| Living in 3D.ts

| Lower Extremity PAD Diagnostic Dilemmas, Disparities, and Patient Centered Outcomes.ts

| Management of Pediatric Cardiology and Cardiac Surgery in the Post-COVID World.ts

| Managing the Device Patient in 2021 From Cybersecurity, to MRI and Beyond.ts

| Managing Today’s Advanced Heart Failure Patient.ts

| Men Are From Mars, Women Are From Venus Sex-Specific Risk Factors That Enhance CVD Risk.ts

| Minimally Invasive Therapies and Devices in AHF Featuring the 2021.ts

| MINOCA A Show and Tell With the Experts.ts

| Mitral Valve Disease and Cardiac Arrest Innocent Bystander or Guilty As Charged.ts

| Mitral Valve Interventions Percutaneous Mitral Valve Repair.ts

| Mobile ECG Monitoring How Can We Utilize Wearable Data.ts

| Multimodality Cardiac Imaging and Modern Media.ts

| Multimodality Imaging in Cardio-Oncology.ts

| Multimodality Imaging in Challenging Cases of Infective Endocarditis.ts

| Multimodality Imaging of Athletes What Do The New Consensus Statement Teach Us.ts

| Must Know Tips for Publishing in JACC Journals.ts

| Myocarditis and Heart Failure.ts

| New AHAACC Valve Guidelines A Paradigm Shift in Management of Severe Aortic Stenosis.ts

| New and Emerging Breakthrough Medicines for HFrEF! Now What Do We Do.ts

| New Hypertension Therapies in Asian People.ts

| New Innovations in Cardiovascular Imaging Incorporating Artificial Intelligence Into Daily Practice.ts

| New Recommendations on How to Monitor Patients Post TAVRSAVR.ts

| Nuts & Bolts of Pregnancy and Congenital Heart Disease.ts

| Obstructive Sleep Apnea and Cardiovascular Outcomes What do Cardiologists Need to Know.ts

| Off-Beat Topics in Heart Failure Improving Dysfunction By Treating the Rhythm.ts

| Optimizing LDL-C Management in Recent MI Patients A Focus on Multidisciplinary Care Team Approach.ts

| Optimizing the Patient Care Pathway and LDL-C Management in Patients with Recent MI.ts

| Overcoming Therapeutic Inertia Maximizing Guideline Driven Medical Therapy in Heart Failure.ts

| Parenteral Antithrombotic Therapies for ACS and PCI.ts

| PCI in patients with CKD Insights from a nephrology and interventional cardiology partnership.ts

| Perlas practicas en manejo de lipidos.ts

| Perspectives on Pulmonary Hypertension.ts

| Pharmacologic and Lifestyle Management for ISHD Why Disparities in Care Matter.ts

| Pharmacology I Expanding the Cardiovascular Pharmacology Toolbox.ts

| Pharmacology II Tackling the Supersized Epidemic of Cardio-diabetes.ts

| Pharmacology III An Ounce of Prevention is Worth a Pound of Cure – Advances in Cardio-Oncology.ts

| Pharmacotherapy Considerations in Cardio-Obstetrics.ts

| Polite Parlays in Pulmonary Hypertension.ts

| Potential Mechanisms Responsible for the Effects of Incretins on Atherosclerosis.ts

| Practical Pearls on ASCVD and Lipid Management.ts

| Pre-operative Care for Non-Cardiac Surgery Emerging Strategies and Ongoing Controversies.ts

| Precision in Classification and Treatment of Heart Failure One Size Does Not Fit All.ts

| Precision PCI in the Real World What Do I Use Every Day.ts

| Proarrhythmia Look Outs! From the ICU to the Food We Eat.ts

| Professional Advancement Across the Academic Cardiology Life Course.ts

| Professionalism and Ethics in Cardiology.ts

| Progression of Pulmonary Arterial Hypertension Pharmacotherapy Plainly Played-out in a Patient Case.ts

| Protected PCI Diagnosis and Treatment of High-Risk and Complex Coronary Disease for Superior Long-term Outcomes.ts

| Pulmonary Hypertension Primer WHO Are the Groups.ts

| Raising the Clinical Suspicion for Hypertrophic Cardiomyopathy.ts

| Rapid Fire Session on Valvular Heart Disease.ts

| Re-imagining the 90-Day High-Risk Period Post-AMI Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization.ts

| Recent Trials in SIHD Translating Results into Clinical Practice.ts

| Registries in Cardiac Imaging How Will they Change Clinical Practice.ts

| Repair Is Not Correction Long Term Follow-up of Surgery for Congenital Heart Disease.ts

| Return To Play What The Experts Would Do.ts

| Reversible Cardiomyopathies Arrhythmias, Pacing, Dyssynchrony and Inflammation.ts

| Right Sided Valve Interventions.ts

| Role of Multimodality Imaging in Diagnosis and Management of Cardiovascular Complications in Patients with COVID-19.ts

| Sex Differences in Arrhythmias.ts

| Shock Teams and Shock Docs.ts

| So You Want To Be a Chief of Cardiology.ts

| Star Wars What Does the Future Hold for EP.ts

| Sticky Situations for Revascularization in SIHD When the Evidence Is Limited but Opinions Are Vast.ts

| Strategies for Bleeding Avoidance After Complex PCI.ts

| Streamlining diagnosis and treatment in chronic coronary artery disease.ts

| Stress Echo Beyond Obstructive CAD.ts

| Stroke Prophylaxis Treating the Untreated.ts

| Structural Complications & How to Deal with Them.ts

| Structural Heart Disease Challenges in 2021 – Aortic, Mitral and Tricuspid Diseases, Hypertrophic Cardiomyopathies.ts

| Tackling Cardiometabolic Risk A Case Based Discussion.ts

| The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and How DISCUSSION.ts

| The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and HowDIAPOSITIVAS.ts

| The Constant Debate TAVR Versus SAVR – One Size Does Not Fit All.ts

| The European Heart Journal’s Year in Cardiovascular Medicine.ts

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 1.mp4

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 2.mp4

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 4.mp4

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 5.mp4

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand3.mp4

| The Future of Dyslipidemia Management.ts

| The TeleHealth Cardiac Team Challenges and Opportunities.ts

| The Time Has Come For Systematic Screening For Asymptomatic Atrial Fibrillation.ts

| The US-China Consensus on High Efficiency PVI Using RF Energy in Patients with Paroxysmal AF and AF Workflow Sharing.ts

| Thrombosis & Prevention in COVID-19 What Are We Missing.ts

| To Right a Wrong in Heart Failure.ts

| Top Indications for Cardiovascular Magnetic Resonance in Modern Cardiology.ts

| Topical Topics in Pulmonary Arterial Hypertension.ts

| Tough Choices Cases in Cardiogenic Shock.ts

| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 1.mp4

| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 2.mp4

| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 3.mp4

| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 4.mp4

| Transcatheter Mitral Valve Replacement Expanding Indications and Trial Update.ts

| Translational Cardiac Anatomy.ts

| Treat the Pump or Treat the Rhythm Let’s Talk About Both.ts

| Treating Comorbidities to Treat Heart Failure Sleep, Exercise, Weight Loss, Iron and More.ts

| Tricuspid Regurgitation No Longer The Forgotten Valve.ts

| Under the Bright Light Debates in Interventional Cardiology.ts

| Understanding the Impact of Lp(a) in ASCVD A focus on added CV risk, guidelines, and testing.ts

| Unfolding the Mysteries of Cardiac Amyloidosis.ts

| Uniquely Bicuspid Valve Two Leaflets and A Tool Kit.ts

| Universal Definition of Heart Failure.ts

| Updates in Management of Hypertrophic Cardiomyopathy.ts

| Use of Direct Oral Anticoagulants in Special Populations Complex Dosing Strategies and Complicated Patients.ts

| Valvular Conundrums Grey Area Cases, What the Experts Think.ts

| VASCEPA® (icosapent ethyl) Elevating the Standard of Care.ts

| Vascular Manifestations of COVID-19 Around the Globe.ts

| Vasculo-Oncology Lessons Learned for Clinical Practice in 2021.ts

| Venous Interventions 2021.ts

| Venous Thromboembolism Current Controversies and Practical Management.ts

| Virtual Outpatient Experience for Cardiac Electrophysiologists High Yield Topics.ts

| Vulnerable Plaques Intervention or Pharmacologic Therapy.ts

| Watchman Transmission.ts

| What Can We Learn From Each Other For Global Heart Failure Care.ts

| What You Don’t Know Can’t Help Them – Remote Management of Patients Using Wearables.ts

| What’s In a Name Practicalities of the 4th Universal Definition of MI.ts

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 1.mp4

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 2.mp4

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 3.mp4

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 4.mp4

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 5.mp4

| When Fat Overpowers Muscle Obesity and the HFpEF Epidemic.ts

| Working Together to Improve Pediatric and Congenital Heart Disease Care Around the World 5.ts

| World Heart Federation Featured Research With Year in Review.ts

| Yes, No, Maybe How to Diagnose and Treat INOCA (Ischemia and No Obstructive Coronary Artery Disease) Today.ts

| Your PVI Toolkit.ts

Go to full site